WHO Authorizes Biological E Limited As Additional Production Facility For Johnson & Johnson's COVID-19 Vaccine

US Embassy in India congratulated Biological E. Limited, a Hyderabad-based pharmaceutical, and vaccines firm, on receiving WHOs approval as an additional site for the production of Janssen/Johnson & Johnson COVID-19 vaccine. Recently, Drug Controller General of India authorized the Corbevax vaccine on June 4. Corbevax is a COVID-19 booster dosage for those aged 18 and above, administered six months after an initial immunization (two doses) of Covaxin or Covishield vaccinations.